Novartis India Ltd
NSE:NOVARTIND

Watchlist Manager
Novartis India Ltd Logo
Novartis India Ltd
NSE:NOVARTIND
Watchlist
Price: 672.25 INR
Market Cap: ₹16.6B

Profitability Summary

Novartis India Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Novartis India Ltd

Margins Comparison
Novartis India Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Novartis India Ltd
NSE:NOVARTIND
16.6B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Novartis India Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Novartis India Ltd
NSE:NOVARTIND
16.6B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Novartis India Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate